Zacks Research Upgrades Privia Health Group (NASDAQ:PRVA) to “Hold”

Privia Health Group (NASDAQ:PRVA) was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Tuesday,Zacks.com reports.

A number of other equities research analysts also recently weighed in on PRVA. JMP Securities reissued a “market outperform” rating and set a $29.00 price target on shares of Privia Health Group in a research note on Monday, April 28th. Evercore ISI dropped their price target on shares of Privia Health Group from $30.00 to $28.00 and set an “outperform” rating for the company in a research note on Wednesday, July 9th. JPMorgan Chase & Co. boosted their price target on shares of Privia Health Group from $29.00 to $32.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 28th. Piper Sandler dropped their price target on shares of Privia Health Group from $36.00 to $35.00 and set an “overweight” rating for the company in a research note on Monday, August 11th. Finally, Barclays boosted their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “equal weight” rating in a research note on Tuesday, May 27th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $28.00.

Privia Health Group Trading Down 0.3%

Shares of NASDAQ PRVA opened at $21.15 on Tuesday. Privia Health Group has a 1-year low of $16.47 and a 1-year high of $26.09. The company has a market cap of $2.60 billion, a PE ratio of 192.29, a P/E/G ratio of 3.07 and a beta of 0.80. The company has a 50-day moving average of $20.98 and a two-hundred day moving average of $22.72.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.03). The business had revenue of $521.15 million for the quarter, compared to the consensus estimate of $466.97 million. Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%.The company’s quarterly revenue was up 23.4% on a year-over-year basis. During the same period last year, the firm earned $0.19 earnings per share. Privia Health Group has set its FY 2025 guidance at EPS. As a group, equities research analysts forecast that Privia Health Group will post 0.14 earnings per share for the current year.

Institutional Investors Weigh In On Privia Health Group

Several large investors have recently bought and sold shares of the company. US Bancorp DE increased its stake in Privia Health Group by 2.4% in the first quarter. US Bancorp DE now owns 18,487 shares of the company’s stock valued at $415,000 after purchasing an additional 429 shares in the last quarter. Park Avenue Securities LLC boosted its holdings in shares of Privia Health Group by 3.6% in the first quarter. Park Avenue Securities LLC now owns 15,229 shares of the company’s stock valued at $342,000 after buying an additional 532 shares during the period. Bank of Montreal Can boosted its holdings in shares of Privia Health Group by 1.9% in the second quarter. Bank of Montreal Can now owns 28,694 shares of the company’s stock valued at $660,000 after buying an additional 543 shares during the period. CWM LLC boosted its holdings in shares of Privia Health Group by 50.3% in the first quarter. CWM LLC now owns 1,804 shares of the company’s stock valued at $40,000 after buying an additional 604 shares during the period. Finally, Financial Management Professionals Inc. boosted its holdings in shares of Privia Health Group by 28.7% in the first quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company’s stock valued at $76,000 after buying an additional 754 shares during the period. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.